1. EV-Associated miRNAs from Peritoneal Lavage are a Source of Biomarkers in Endometrial Cancer
- Author
-
Isabel Sáenz Hernández, Antonio Gil-Moreno, Xavier Matias-Guiu, Berta Roman-Canal, José M. Porcel, Julia Ponomarenko, Eva Colas, Maria Ruiz-Miró, Esperanza Gonzalez, Juan M. Falcón-Pérez, Ivanna Llordella, Sarah Bonnin, Sonia Gatius, Cristian Pablo Moiola, Xavier González-Tallada, Institut Català de la Salut, [Roman-Canal B] Departament de Patologia i Genètica Molecular, Grup de Patologia Oncològica, Institut de Recerca Biomèdica de Lleida, Lleida, Spain. Universitat de Lleida, Lleida, Spain. Departament de Patologia, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Spain. Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet de Llobregat, Barcelona, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Moiola CP] Departament de Patologia i Genètica Molecular, Grup de Patologia Oncològica, Institut de Recerca Biomèdica de Lleida, Lleida, Spain. Universitat de Lleida, Lleida, Spain. Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca, Barcelona, Spain. [Gatius S, Ruiz-Miró M] Departament de Patologia i Genètica Molecular, Grup de Patologia Oncològica, Institut de Recerca Biomèdica de Lleida, Lleida, Spain. Universitat de Lleida, Lleida, Spain. [Bonnin S] Centre de Regulació Genòmica (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain. [González E] Exosomes Laboratory and Metabolomics Platform. CIC bioGUNE, CIBEREHD Bizkaia Technology Park, Derio, Spain. [Gil-Moreno A] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. Servei de Ginecologia Oncològica, Hospital Universitari Vall d'Hebron, Barcelona, Spain. [Colas E] Grup de Recerca Biomèdica en Ginecologia, Vall d’Hebron Institut de Recerca, Barcelona, Spain, and Vall d'Hebron Barcelona Hospital Campus
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,factores biológicos::biomarcadores::marcadores tumorales [COMPUESTOS QUÍMICOS Y DROGAS] ,Exosomes ,0302 clinical medicine ,Endometrial cancer ,Other subheadings::/diagnosis [Other subheadings] ,Uterine cancer ,Biochemical markers ,peritoneal lavage ,Extracellular vesicles ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,microRNAs ,030220 oncology & carcinogenesis ,endometrial cancer ,miRNAs ,Marcadors bioquímics ,MiRNAs ,extracellular vesicles ,medicine.medical_specialty ,Otros calificadores::/diagnóstico [Otros calificadores] ,exosomes ,lcsh:RC254-282 ,Article ,uterine cancer ,03 medical and health sciences ,Internal medicine ,microRNA ,medicine ,TaqMan ,Liquid biopsy ,Biological Factors::Biomarkers::Biomarkers, Tumor [CHEMICALS AND DRUGS] ,Peritoneal lavage ,MicroARN ,liquid biopsy ,business.industry ,ascitic fluid ,Ascitic fluid ,Marcadors tumorals ,Cancer ,biomarkers ,nucleótidos y nucleósidos de ácidos nucleicos::nucleótidos y nucleósidos de ácidos nucleicos::ácidos nucleicos::ARN::ARN antiparalelo::nucleótidos y nucleósidos de ácidos nucleicos::ácidos nucleicos::ARN::microARN [COMPUESTOS QUÍMICOS Y DROGAS] ,Histology ,Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Endometrial Neoplasms [DISEASES] ,Endometri - Càncer - Diagnòstic ,medicine.disease ,Microvesicles ,Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::RNA::RNA, Antisense::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acids::RNA::MicroRNAs [CHEMICALS AND DRUGS] ,030104 developmental biology ,Càncer d'endometri ,business ,neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias endometriales [ENFERMEDADES] ,Biomarkers - Abstract
Ascitic fluid; Biomarkers; Endometrial cancer Líquido ascítico; Biomarcadores; Cáncer de endometrio Ascites; Biomarcadors; Càncer d'endometri Endometrial cancer (EC) is the sixth most common cancer in women worldwide and is responsible for more than 89,000 deaths every year. Mortality is associated with presence of poor prognostic factors at diagnosis, i.e., diagnosis at an advanced stage, with a high grade and/or an aggressive histology. Development of novel approaches that would permit us to improve the clinical management of EC patients is an unmet need. In this study, we investigate a novel approach to identify highly sensitive and specific biomarkers of EC using extracellular vesicles (EVs) isolated from the peritoneal lavage of EC patients. EVs of peritoneal lavages of 25 EC patients were isolated and their miRNA content was compared with miRNAs of EVs isolated from the ascitic fluid of 25 control patients. Expression of the EV-associated miRNAs was measured using the Taqman OpenArray technology that allowed us to detect 371 miRNAs. The analysis showed that 114 miRNAs were significantly dysregulated in EC patients, among which eight miRNAs, miRNA-383-5p, miRNA-10b-5p, miRNA-34c-3p, miRNA-449b-5p, miRNA-34c-5p, miRNA-200b-3p, miRNA-2110, and miRNA-34b-3p, demonstrated a classification performance at area under the receiver operating characteristic curve (AUC) values above 0.9. This finding opens an avenue for the use of EV-associated miRNAs of peritoneal lavages as an untapped source of biomarkers for EC. Funded by Generalitat de Catalunya, grant numbers SLT002/16/00274, 2017SGR1661, and 2017SGR1368; by CIBERONC, grant numbers CB16/12/00328 and CB16/12/00231; by Instituto Salud Carlos III, grant number PIE15/00029 and by Asociación Española Contra el Cáncer (AECC), grant number GCTRA1804MATI
- Published
- 2019